AMANDA FALVEY: Open Payments
NPI 1447659016 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 13 payments from 11 companies in 2025. Trend: 2023 $49 · 2024 $0 · 2025 $327
Food & beverage: $180Education: $147
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $75 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
| ABBVIE INC. | 3 | $50 |
| GENZYME CORPORATION | 1 | $20 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Verrica Pharmaceuticals Inc. | 1 | $16 |
| PFIZER INC. | 1 | $16 |
| LEO Pharma Inc. | 1 | $15 |
Products named: DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, Zoryve, Sotyktu, YCANTH, CIBINQO.
Industry payments across MA — which companies pay providers there.
